Editorial
Leukemia (2007) 21, 383–386. doi:10.1038/sj.leu.2404509
Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations
A Gratwohl1, H Baldomero1, A Schwendener2, M Gratwohl1, A Urbano-Ispizua3 and K Frauendorfer2 For the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT) (JACIE)
- 1Hematology, Department of Medicine, University Hospital Basel, Basel, Switzerland
- 2Institute for Operations Research and Computational Finance, University of St Gallen, St Gallen, Switzerland
- 3JACIE office, Hospital Clinic, Barcelona, Spain. E-mail: hematology@uhbs.ch
